Trial of Abscess Drainage Techniques
Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · Sep 9, 2015
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
This prospective randomized single blind clinical trial will be conducted in a suburban pediatric emergency department that treats approximately 29,000 patients per year. Patients between 0-17 years with a superficial skin or soft tissue abscess larger than 3 cm that would be appropriate for ED I\&D and outpatient management will be screened for inclusion. Patients will be excluded if they are immunocompromised (taking chemotherapy, steroid or bioactive medications or having diabetes mellitus), require a subspecialist for drainage or require hospitalization. Subjects will be required to pro...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Pediatric patient (0-18 years old) with abscess over 3 cm which can be drained in the ER and does not require hospitalization
- Exclusion Criteria:
- • Diabetes
- • immunocompromised
- • cancer
- • chemotherapy
- • requires hospitalization for treatment of abscess
- • abscess felt not drainable in the ER by ER physicians
Trial Officials
Milan Nadkarni, MD
Principal Investigator
Wake Forest University Health Sciences
About Wake Forest University Health Sciences
Wake Forest University Health Sciences is a leading academic research institution dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on multidisciplinary collaboration, the organization leverages its extensive expertise in medical research, patient care, and education to develop and evaluate new therapies and interventions. Committed to improving patient outcomes and public health, Wake Forest University Health Sciences fosters a dynamic environment for scientific inquiry, engaging in a wide range of clinical studies that address pressing health challenges. Through its rigorous methodologies and ethical standards, the institution aims to contribute significantly to the medical field and enhance the quality of life for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials